We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Proteome Sciences Plc | LSE:PRM | London | Ordinary Share | GB0003104196 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.09 | 2.73% | 3.39 | 3.00 | 3.78 | - | 17,740 | 16:35:09 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 7.78M | 1.33M | 0.0045 | 7.33 | 9.74M |
Date | Subject | Author | Discuss |
---|---|---|---|
10/1/2024 10:23 | wasjobber, I agree, 32-plex TMT Pro will provide a big increase to the revenue figures. But I've just received information from someone I trust impeccably that the Randox Stroke test will definitely be released during the course of this year. Now that will really put a rocket under the revenue figures. | pools2 | |
10/1/2024 10:15 | Given the history and the timespan over which many have held, it may be that the market is waiting to see "earning potential" turn into "earning". Show us the money! "its will also provide a dramatic increase in revenues". Go on, then. | jeffian | |
10/1/2024 09:54 | I'm not sure many people have understood the implications of Proteome Sciences now using their 32-plex TMTpro reagents in their biomarker services business. Quite simply it immediately almost doubles the sampling capacity and revenue earning potential of their current laboratory services business. Proteome Sciences have said that they'll soon be signing much bigger biomarker services contracts. Also, when Thermo Scientific release the commercial 32-plex TMTpro reagents in a few months, its will also provide a dramatic increase in revenues. STRONG BUY | wasjobber | |
04/1/2024 16:33 | 1 trade in the end, a STRONG BUY as well, 7 (seven) of them. | james japp | |
04/1/2024 10:08 | CJP doesn't want profit,it messes with the endgame. | peverill | |
04/1/2024 09:18 | No trades reported so far today, I note. | james japp | |
04/1/2024 09:16 | Looks like Proteome Sciences are in good company, with impressive growth opportunities. STRONG BUY | wasjobber | |
03/1/2024 20:09 | The new facility will be handy for providing wages for more mates. its bound to need a couple of directors and managers, supervisors. Im sure they will have people lined up for that. that should take care of £500,000 + Not to mention other costs like rent, rates, energy, equipment, and other staff. and people are surprised no one is buying. Given its taken them 30yrs to make their first and only profit and now back at a loss it had better start making money quick. | madmick | |
03/1/2024 19:03 | It's not a wonder staff don't buy,they know what the prospects are of success.The wages are bang on though. | peverill | |
03/1/2024 17:38 | Not even worth 2p imo | mashman | |
02/1/2024 20:15 | There were 2 trades totalling 14000, both sells. | james japp | |
02/1/2024 17:00 | Zero trades on ADVFN, they need to deliver in 24, now they have a prime location, it should be all out action | goggin | |
02/1/2024 11:58 | 59582 re 59580 see 59581 | james japp | |
02/1/2024 11:56 | wasjobber, Agreed, with TMT Pro 32-plex, order size and therefore revenue will increase significantly. | pools2 | |
02/1/2024 11:39 | Amazing isnt it! So good that there has been 1 (one) trade reported so far. | james japp | |
02/1/2024 11:37 | So double good news this morning. Not only do we get confirmation of the US lab now fully open, but also both of PRM's labs are now using the new TMT Pro 32-plex reagents. This will increase volume and therefore revenues. | wasjobber | |
02/1/2024 08:02 | As 2024 is my Silver Jubilee (invested here) I clearly have patience but remain optimistic that the launch of our new lab will soon be complemented by announcements of material contracts | base7 | |
02/1/2024 07:45 | Yes I agree WHH. Revenues should get back on track this year, partly helped by this update. HNY to all. W41 | wrighty41 | |
02/1/2024 07:27 | Well done Proteome Sciences. In my honest opinion this is good strategic move as PS are now operational in two of the world great markets with a range of cutting edge technology that can service these markets. We now need to see the benefits accrue. I feel confident that they will. Good News to start the New Year. | wellhonedhutch | |
02/1/2024 07:18 | Same to you Richard. | canaletto | |
01/1/2024 16:10 | May I wish all posters a very prosperous New Year (happy too!) That includes the wayward Proteome bashers, provided their prosperity comes from elsewhere and not from shorting Proteome! | goatherd | |
22/12/2023 21:33 | Mad Deer Disease: a warning from history | small crow |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions